Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.
about
MIF: Implications in the Pathoetiology of Systemic Lupus ErythematosusDiversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular PerspectivesA Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)Structural Interactions Dictate the Kinetics of Macrophage Migration Inhibitory Factor Inhibition by Different Cancer-Preventive IsothiocyanatesCharacterization of Molecular Determinants of the Conformational Stability of Macrophage Migration Inhibitory Factor: Leucine 46 Hydrophobic PocketMIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrationsTargeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitmentMacrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory responseA Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent InhibitorsScreening for chemicals that affect hair cell death and survival in the zebrafish lateral lineNeutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.Benzisothiazolones as modulators of macrophage migration inhibitory factor.Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.Homotrimeric macrophage migration inhibitory factor (MIF) drives inflammatory responses in the corneal epithelium by promoting caveolin-rich platform assembly in response to infection.Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.Spirohexenolide A targets human macrophage migration inhibitory factor (hMIF)Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.Cell Signaling with Extracellular Thioredoxin and Thioredoxin-Like Proteins: Insight into Their Mechanisms of Action.Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning.MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS.Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.Discovery of Novel Inhibitors of the Tautomerase Activity of Macrophage Migration Inhibitory Factor (MIF).Activity-Based Proteome Profiling Probes Based on Woodward's Reagent K with Distinct Target Selectivity.Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation.
P2860
Q26776111-926EAD4A-64D7-4EF6-9125-0E3882735774Q26782778-21F12436-0A35-4A4E-A2F3-6ACB4BA38799Q27670700-23A1D3E2-70CC-4FB4-894F-F8F37E149F18Q27671784-C8786EB0-2C72-4828-A524-9FF6DBA37871Q27673971-E3D8BDD2-7986-4A61-ABE4-E68752A734EFQ27678661-214961F8-BC98-47BD-882A-16106660173BQ27684665-0FF9D1C0-7950-4C2A-8F16-DF1F90EFF7A2Q28728841-D1F16481-E114-48CB-8FFF-1F83B0498D87Q28830113-51BB63C9-5571-4781-B51E-711EBB086EDCQ30454013-63192598-38D6-47EE-A2D7-7372566B1831Q34124862-595D21E9-66F5-4D54-BC3B-11C7CA67B814Q34543093-3FC5A28F-3E31-4EEE-ADD0-FA9441A6074BQ35114713-DAF46781-7D1A-4932-9E10-C14914B066B9Q36059818-7E7038D1-0B5B-4604-AC23-FA14B5F84002Q36708545-6B455526-846D-408E-9DB6-EE83E8467BD5Q36848077-F21B1AFD-F2CF-460C-8884-7E39951D1D2CQ36996170-167B00C8-B8F3-49A2-B3CB-43DE4E249FB3Q37117350-F60A79E3-86C8-422A-A494-A1622B03D3DCQ37604131-35E4228F-C986-4A33-AD46-85E6B09B7E3EQ37826194-B25B8FCB-0CDF-498A-8264-1DEDCAE747CBQ38700157-709E67CF-A664-4272-8BC3-58BF1D9D5F8DQ39340752-C0951E58-F25C-4835-A9EB-64B6DEAFF1D6Q43375855-50F2AB71-7E3A-4DB1-818D-E3C39C153536Q44806845-3FE03C8D-59C4-4C66-B08A-A53E2AA42939Q47108533-F3FBF7DE-E800-4695-AB79-3B87CA14E6A1Q47285998-58825792-FD77-4310-978C-5FF4CE53998FQ47839028-C384A47D-1A38-4C03-A815-234AD6EF5058Q51734324-C2DA020D-5AB5-423D-8EAF-3D46B488C8FBQ52633245-7D97F719-442D-45F2-AAA0-BAB1DB3BC255Q52715769-89B92A00-5885-4907-8B6C-8948FAC65A7CQ53161443-C0A742AF-0DF7-4C2A-AEFD-FCE8944C883CQ53745757-233B79F4-756C-40E5-AB12-BB2A057AD73BQ55024863-C221A647-DA68-4C80-8D8D-ADCFEFC88472
P2860
Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification and characteriz ...... distinct mechanisms of action.
@ast
Identification and characteriz ...... distinct mechanisms of action.
@en
type
label
Identification and characteriz ...... distinct mechanisms of action.
@ast
Identification and characteriz ...... distinct mechanisms of action.
@en
prefLabel
Identification and characteriz ...... distinct mechanisms of action.
@ast
Identification and characteriz ...... distinct mechanisms of action.
@en
P2093
P2860
P50
P356
P1476
Identification and characteriz ...... distinct mechanisms of action.
@en
P2093
Damla Pinar Karpinar
Farah El-Turk
Hajer Ouertatani-Sakouhi
Jürgen Bernhagen
Manfred Dewor
P2860
P304
26581-26598
P356
10.1074/JBC.M110.113951
P407
P50
P577
2010-06-01T00:00:00Z